Is BPC-157 legal in the US?
BPC-157 isn't simply legal or illegal — the answer depends on which of two regulatory tracks your provider operates on. Here's how to tell.
Contents▾
[!DISCLAIMER] This content is for educational and research purposes only. It does not constitute medical advice. Consult a qualified healthcare provider before making any health decisions.
BPC-157 is not a controlled substance under US law, and it is not FDA-approved. It doesn't fit cleanly into any standard regulatory category — which is exactly why the question "is it legal?" produces conflicting answers. The honest answer is that legality depends on which of two regulatory tracks your provider operates on. Two separate supply chains for BPC-157 exist simultaneously in the US: a licensed compounding pharmacy route requiring a valid prescription, and a research chemical vendor route that does not. Which track your provider is on shapes your regulatory exposure.
[!TLDR]
- BPC-157 is not scheduled as a controlled substance and has no FDA-approved use — it exists in a regulatory gap between drug and research compound.
- Two US supply chains operate simultaneously: 503A compounding pharmacies (prescription required, state-licensed oversight) and research chemical vendors ("for laboratory use only" labeling, no prescription required).
- The prescription requirement is the clearest single indicator of which track a provider is on.
- Of 556 active US providers carrying BPC-157 in the PeptideBase directory (as of April 2026), 85.3% are clinics — only 3.8% are licensed 503A compounding pharmacies.
- "Legal to operate" and "quality-controlled" are separate questions — the regulatory track describes legal exposure, not product purity.
BPC-157's regulatory status: neither approved nor scheduled
BPC-157 (Body Protection Compound-157) is a synthetic peptide that has been the subject of animal model research on tissue repair and gastrointestinal function. It is not listed on the DEA's Controlled Substances schedule. It has no FDA-approved indication. It is not recognized as a dietary supplement under DSHEA.
Under FDA authority, a substance becomes a regulated drug when it is intended to diagnose, cure, treat, mitigate, or prevent disease — or to affect the structure or function of the body. BPC-157, when sold for human administration, falls under this definition. That makes it an unapproved drug, not a freely available compound.
The absence of DEA scheduling creates a common misreading: "not scheduled" gets read as "legal." What it actually means is that BPC-157 doesn't carry the criminal exposure of a scheduled substance. It doesn't mean the FDA lacks authority over it.
For a detailed overview of the research on BPC-157, see the BPC-157 compound profile in the PeptideBase research library.
Track 1: the 503A compounding pharmacy route
503A compounding pharmacies are state-licensed facilities permitted to prepare compounded medications for individual patients with a valid prescription from a licensed prescriber. Under this framework, a physician, nurse practitioner, or other authorized prescriber can order BPC-157 for a specific patient with a documented clinical rationale.
What the 503A track requires:
- A valid prescription from a licensed prescriber
- An active state board of pharmacy license held by the compounding facility
- Compounding for a specific patient — not bulk preparation for general sale
- State regulatory oversight via the applicable board of pharmacy
The prescriber-patient relationship creates a documented record. The pharmacy license creates an accountability structure. Neither independently guarantees product quality — but both create oversight the second track does not.
[!STAT] Of 556 active US providers carrying BPC-157 in the PeptideBase directory (as of April 2026), 85.3% are clinics operating through a patient-provider relationship. Only 21 providers (3.8%) are licensed 503A pharmacies dispensing directly.
# Provider breakdown — PeptideBase directory (April 2026)
clinic|85.3|Clinics
online_vendor|6.7|Online Vendors
telehealth|4.0|Telehealth
pharmacy_503a|3.8|503A Pharmacies
physician|0.4|Physicians
To verify a pharmacy's license, search nabp.pharmacy — the National Association of Boards of Pharmacy's public database. A licensed 503A facility will appear with its license status and any disciplinary history.
For more on evaluating compounding pharmacies, see How to find a 503A compounding pharmacy for peptides.
Track 2: the research chemical vendor route
Research chemical vendors sell BPC-157 labeled "for laboratory use only" or "not for human consumption." This is a legal positioning mechanism — it frames the compound as a research reagent rather than a drug for human use, placing it outside the regulatory framework that applies to drugs sold for human administration.
| 503A Compounding Pharmacy | Research Chemical Vendor | |
|---|---|---|
| Prescription required | ✓ Yes | ✗ No |
| License publicly searchable | ✓ nabp.pharmacy | ✗ N/A |
| State board oversight | ✓ Yes | ✗ No |
| Quality guarantee | Neither track guarantees this | Neither track guarantees this |
The "for laboratory use only" label is not a quality statement. It describes the vendor's legal category, not the product's purity, peptide concentration, sterility, or testing rigor. A vendor can operate on this track with rigorous third-party HPLC testing — or with none.
The FDA retains authority to act against products it determines are being sold as unapproved drugs regardless of labeling. Historically, enforcement has focused on manufacturers rather than individual buyers — but that posture is neither permanent nor guaranteed, and it doesn't resolve the quality-control question independently.
To understand what quality documentation to look for from any vendor, see Research peptide vendors: what COA and HPLC testing actually mean.
How to tell which track your provider is on
[!KEY] The prescription requirement is the clearest signal. A 503A compounding pharmacy cannot legally dispense a compounded medication without a valid prescription from a licensed prescriber. A provider selling BPC-157 without requiring a prescription is not on the 503A track — regardless of how they describe themselves.
If the provider claims to be a compounding pharmacy: Search nabp.pharmacy. Licensed 503A pharmacies are listed with license status and disciplinary history. If the provider doesn't appear, ask for their state board of pharmacy license number directly.
If the provider is a clinic or telehealth platform: Verify the prescribing physician or NP's license through your state's public medical license lookup. A consultation process that produces a prescription without a documented clinical assessment is a different arrangement than a legitimate prescriber-patient relationship.
If the provider is a research chemical vendor: Focus on quality documentation: third-party COA data, HPLC test results, and the identity of the testing lab. The "for lab use only" framing is standard — the meaningful difference is in what quality documentation they provide.
The BPC-157 providers page on PeptideBase lists 556 active US providers filterable by provider type, to help distinguish between the two tracks.
Frequently asked questions
Is BPC-157 a controlled substance in the US?
No. BPC-157 is not listed on the DEA's Controlled Substances schedule. However, it is classified as an unapproved drug under FDA authority when sold for human use. Not being scheduled is not the same as being freely legal for human administration — the two designations address different regulatory questions.
Can a US compounding pharmacy legally make BPC-157?
A 503A compounding pharmacy can compound BPC-157 for an individual patient with a valid prescription from a licensed prescriber. The pharmacy must hold an active state board license, and the compound must be prepared for a specific patient rather than in bulk. Verify the pharmacy's license at nabp.pharmacy before proceeding.
What does "for laboratory use only" actually mean?
It's a legal labeling mechanism that positions the product as a research reagent rather than a drug for human use — affecting which regulatory framework applies to the vendor. It is not a statement about product quality, purity, or compliance with any testing standard. Two vendors can use this label and have entirely different quality control practices.
Why do most sources give a simple yes or no on BPC-157's legal status?
Because collapsing two distinct regulatory frameworks into a single verdict is simpler. A "yes, it's legal" answer typically refers to the research chemical track — BPC-157 is not scheduled, and buyer-level enforcement has not been a focus. A "gray area" answer reflects the FDA's authority over unapproved drugs. Both framings are accurate within their specific context.
How do I find a provider using the 503A compounding route?
Start by filtering for clinic and telehealth providers in the PeptideBase directory — these operate through prescriber-patient relationships. Confirm the provider requires a telehealth or in-person consultation before dispensing, verify the prescriber's license through your state's public database, and ask which compounding pharmacy they partner with.
[!DISCLAIMER] Educational information only — not medical advice. No dosing, protocol, or treatment advice is provided or implied.
Find BPC-157 providers in the PeptideBase directory, filterable by provider type and state: View BPC-157 providers →
Last reviewed: April 2026 — Alexandre Sherif Peterson
PeptideBase Directory
Find a Provider Offering BPC-157
Browse verified providers that carry BPC-157 and compare options side by side.
Alexandre Sherif Peterson
Educational content curated by the PeptideBase team. All content is for informational purposes only and does not constitute medical advice.